Evidence map›Paper›PMID 27750279›Full record

ArticleNature2016

T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments.

Edwin D Hawkins, Delfim Duarte, Olufolake Akinduro, Reema A Khorshed, Diana Passaro, Malgorzata Nowicka, Lenny Straszkowski, Mark K Scott, Steve Rothery, Nicola Ruivo and 11 more

Abstract read
In one paragraph

Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 202 citations in OpenAlex.

  1. Article
  2. Article
  3. In situ and real-time monitoring of intracellular activities in single live cells using a nanopore probe.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 3 countries.

Edwin D HawkinsDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, UK.
Delfim DuarteDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, UK.
Olufolake AkinduroDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, UK.
Reema A KhorshedDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, UK.
Diana PassaroThe Francis Crick Institute, Haematopoietic Stem Cell Laboratory, 1 Midland Road, London NW1A 1AT, UK.
Malgorzata NowickaSIB Swiss Institute of Bioinformatics and Institute of Molecular Life Sciences, University of Zurich, Winterthurstrasse 190, 8057 Zurich, Switzerland.
Lenny StraszkowskiStem Cell Regulation Unit, St Vincent's Institute of Medical Research, 41 Victoria Parade Fitzroy, Victoria 3065 Australia.
Mark K ScottDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, UK.
Steve RotheryImperial College Facility for Imaging by Light Microscopy, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, UK.
Nicola RuivoDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, UK.
Katie FosterThe Francis Crick Institute, Haematopoietic Stem Cell Laboratory, 1 Midland Road, London NW1A 1AT, UK.
Michaela WaibelSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia.
Ricky W JohnstoneSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia.
Simon J HarrisonSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia.
David A WestermanSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia.
Hang QuachDepartment of Haematology, St Vincent's Hospital, Fitzroy, Victoria 3065, Australia.
John GribbenCentre of Haemato-Oncology, Cancer Research UK Clinical Centre, Barts Cancer Institute, St Bartholomew's Hospital, Queen Mary University of London, London EC1M 6BQ, UK.
Mark D RobinsonSIB Swiss Institute of Bioinformatics and Institute of Molecular Life Sciences, University of Zurich, Winterthurstrasse 190, 8057 Zurich, Switzerland.
Louise E PurtonStem Cell Regulation Unit, St Vincent's Institute of Medical Research, 41 Victoria Parade Fitzroy, Victoria 3065 Australia.
Dominique BonnetThe Francis Crick Institute, Haematopoietic Stem Cell Laboratory, 1 Midland Road, London NW1A 1AT, UK.
Cristina Lo CelsoDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, UK.
Imperial College London · GBThe Francis Crick Institute · GBPeter MacCallum Cancer Centre · AUSt Vincents Institute of Medical Research · AUQueen Mary University of London · GBSIB Swiss Institute of Bioinformatics · CHSt Vincent's Hospital · AUUniversity of Melbourne · AUUniversity of Zurich · CHWalter and Eliza Hall Institute of Medical Research · AU

Funding

Tissue CoreP01CA081534 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KIPPS, THOMAS J · 2000 to 2016
$59.5M
Cancer Research UK 11831Cancer Research UK 15692NCI NIH HHS P01 CA081534Wellcome Trust
6 · The paper itself

Abstract

It is widely accepted that complex interactions between cancer cells and their surrounding microenvironment contribute to disease development, chemo-resistance and disease relapse. In light of this observed interdependency, novel therapeutic interventions that target specific cancer stroma cell lineages and their interactions are being sought. Here we studied a mouse model of human T-cell acute lymphoblastic leukaemia (T-ALL) and used intravital microscopy to monitor the progression of disease within the bone marrow at both the tissue-wide and single-cell level over time, from bone marrow seeding to development/selection of chemo-resistance. We observed highly dynamic cellular interactions and promiscuous distribution of leukaemia cells that migrated across the bone marrow, without showing any preferential association with bone marrow sub-compartments. Unexpectedly, this behaviour was maintained throughout disease development, from the earliest bone marrow seeding to response and resistance to chemotherapy. Our results reveal that T-ALL cells do not depend on specific bone marrow microenvironments for propagation of disease, nor for the selection of chemo-resistant clones, suggesting that a stochastic mechanism underlies these processes. Yet, although T-ALL infiltration and progression are independent of the stroma, accumulated disease burden leads to rapid, selective remodelling of the endosteal space, resulting in a complete loss of mature osteoblastic cells while perivascular cells are maintained. This outcome leads to a shift in the balance of endogenous bone marrow stroma, towards a composition associated with less efficient haematopoietic stem cell function. This novel, dynamic analysis of T-ALL interactions with the bone marrow microenvironment in vivo, supported by evidence from human T-ALL samples, highlights that future therapeutic interventions should target the migration and promiscuous interactions of cancer cells with the surrounding microenvironment, rather than specific bone marrow stroma, to combat the invasion by and survival of chemo-resistant T-ALL cells.

Indexed as

Neoplasm TransplantationTumor MicroenvironmentAnimalsBone Marrow CellsCell MovementDisease ProgressionFemaleHematopoietic Stem CellsHumansIntravital MicroscopyLeukemia-Lymphoma, Adult T-CellMaleMiceOsteoblastsSingle-Cell Analysis

Identifiers

PMID27750279
PMCPMC5164929
OpenAlexW2534765849

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.